{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "status": "retrieved", "company": "Immunovia", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:10:34Z", "company": "Immunovia AB", "title": "Immunovia publicerar Delårsrapport april-juni 2026", "category": "Halvårsrapport", "date": "2026-08-06", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q2", "period": "2026-q2", "report_key": "2026:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b2811f5df23ff37a6e07020eafddb689b&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q2\\release.txt", "attachments": [ { "label": "Immunovia Delarsrapport Q2 2026.pdf", "url": "https://attachment.news.eu.nasdaq.com/ae1f417bd344855d4ceb5689dc8cbb99a", "final_url": "https://attachment.news.eu.nasdaq.com/ae1f417bd344855d4ceb5689dc8cbb99a", "filename": "Immunovia_Delarsrapport_Q2_2026.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q2\\Immunovia_Delarsrapport_Q2_2026.pdf", "content_type": "application/pdf", "size": 532577, "sha256": "dd64257dad51d8e061ea554c48d6f4705c367b942e47569c3f24b02b0c4de2dc", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q2\\Immunovia_Delarsrapport_Q2_2026.pdf", "filename": "Immunovia_Delarsrapport_Q2_2026.pdf", "extension": ".pdf", "size": 532577, "sha256": "dd64257dad51d8e061ea554c48d6f4705c367b942e47569c3f24b02b0c4de2dc", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q2\\extracted\\Immunovia_Delarsrapport_Q2_2026\\Immunovia_Delarsrapport_Q2_2026.txt", "text_chars": 54040, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q2\\extracted\\Immunovia_Delarsrapport_Q2_2026\\Immunovia_Delarsrapport_Q2_2026.extraction.json" } } ], "announcement_id": "1457082", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:10:40Z", "company": "Immunovia AB", "title": "Rättelse: Immunovia publicerar Delårsrapport januari-mars 2026", "category": "Interimsrapport", "date": "2026-05-07", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b1a6666ce1414ec4a14c8c9fa1bf0d3fd&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "Immunovia Delarsrapport Q1 2026.pdf", "url": "https://attachment.news.eu.nasdaq.com/a9f26903c3283771aae8384f7671d2965", "final_url": "https://attachment.news.eu.nasdaq.com/a9f26903c3283771aae8384f7671d2965", "filename": "Immunovia_Delarsrapport_Q1_2026.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q1\\Immunovia_Delarsrapport_Q1_2026.pdf", "content_type": "application/pdf", "size": 3500722, "sha256": "82e9edf4b17f2d80be0d79e78b699609f88a57293279f46a189ff73ed86cb4b4", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q1\\Immunovia_Delarsrapport_Q1_2026.pdf", "filename": "Immunovia_Delarsrapport_Q1_2026.pdf", "extension": ".pdf", "size": 3500722, "sha256": "82e9edf4b17f2d80be0d79e78b699609f88a57293279f46a189ff73ed86cb4b4", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q1\\extracted\\Immunovia_Delarsrapport_Q1_2026\\Immunovia_Delarsrapport_Q1_2026.txt", "text_chars": 51299, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2026-q1\\extracted\\Immunovia_Delarsrapport_Q1_2026\\Immunovia_Delarsrapport_Q1_2026.extraction.json" } } ], "announcement_id": "1440538", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:10:49Z", "company": "Immunovia AB", "title": "Immunovia publicerar årsredovisningen för 2025", "category": "Bokslut och Verksamhetsberättelse", "date": "2026-04-10", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b4f471ae9e79c966a43e7d980eb4e12c3&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "Immunovia AB publ Arsredovisning 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a003a0716b3c489d57e20b93cb41e4694", "final_url": "https://attachment.news.eu.nasdaq.com/a003a0716b3c489d57e20b93cb41e4694", "filename": "Immunovia_AB_publ_Arsredovisning_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-annual\\Immunovia_AB_publ_Arsredovisning_2025.pdf", "content_type": "application/pdf", "size": 5826660, "sha256": "5835d188655b3c9f74e66c3ca06c35c44edf4fe2635245fa7978fbb34fd49ac5", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-annual\\Immunovia_AB_publ_Arsredovisning_2025.pdf", "filename": "Immunovia_AB_publ_Arsredovisning_2025.pdf", "extension": ".pdf", "size": 5826660, "sha256": "5835d188655b3c9f74e66c3ca06c35c44edf4fe2635245fa7978fbb34fd49ac5", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-annual\\extracted\\Immunovia_AB_publ_Arsredovisning_2025\\Immunovia_AB_publ_Arsredovisning_2025.txt", "text_chars": 180734, "metadata": { "page_count": 71, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-annual\\extracted\\Immunovia_AB_publ_Arsredovisning_2025\\Immunovia_AB_publ_Arsredovisning_2025.extraction.json" } } ], "announcement_id": "1433507", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:10:51Z", "company": "Immunovia AB", "title": "Immunovia publicerar Bokslutskommuniké 2025", "category": "Bokslutskommuniké", "date": "2026-02-24", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b95025f0bd10ccc70b2fd8ceccd20986a&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "Bokslutskommunike 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a9a34f3722386ab8c29d882a04d530924", "final_url": "https://attachment.news.eu.nasdaq.com/a9a34f3722386ab8c29d882a04d530924", "filename": "Bokslutskommunike_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q4\\Bokslutskommunike_2025.pdf", "content_type": "application/pdf", "size": 2984217, "sha256": "2c0698add5bcd649088d1f7d8281bcf564f857711ae658b11c6ef51fe29ac391", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q4\\Bokslutskommunike_2025.pdf", "filename": "Bokslutskommunike_2025.pdf", "extension": ".pdf", "size": 2984217, "sha256": "2c0698add5bcd649088d1f7d8281bcf564f857711ae658b11c6ef51fe29ac391", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q4\\extracted\\Bokslutskommunike_2025\\Bokslutskommunike_2025.txt", "text_chars": 52683, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q4\\extracted\\Bokslutskommunike_2025\\Bokslutskommunike_2025.extraction.json" } } ], "announcement_id": "1422114", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:10:56Z", "company": "Immunovia AB", "title": "Immunovia publicerar Delårsrapport juli-september 2025", "category": "Interimsrapport", "date": "2025-11-26", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b9623e7e118c752eb34a564057ac11d47&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "Immunovia Delarsrapport Q3 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a54474f94e81f22f8f79db9eea5345820", "final_url": "https://attachment.news.eu.nasdaq.com/a54474f94e81f22f8f79db9eea5345820", "filename": "Immunovia_Delarsrapport_Q3_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q3\\Immunovia_Delarsrapport_Q3_2025.pdf", "content_type": "application/pdf", "size": 2598961, "sha256": "b271e34cd6d179a57b367446b5b96b4cc5b4112ae24b7946235b01bd68a801dd", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q3\\Immunovia_Delarsrapport_Q3_2025.pdf", "filename": "Immunovia_Delarsrapport_Q3_2025.pdf", "extension": ".pdf", "size": 2598961, "sha256": "b271e34cd6d179a57b367446b5b96b4cc5b4112ae24b7946235b01bd68a801dd", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q3\\extracted\\Immunovia_Delarsrapport_Q3_2025\\Immunovia_Delarsrapport_Q3_2025.txt", "text_chars": 56928, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q3\\extracted\\Immunovia_Delarsrapport_Q3_2025\\Immunovia_Delarsrapport_Q3_2025.extraction.json" } } ], "announcement_id": "1402784", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:11:00Z", "company": "Immunovia AB", "title": "Immunovia publicerar Delårsrapport januari-juni 2025", "category": "Halvårsrapport", "date": "2025-08-28", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b8b0daac652727508919c33b0b9551583&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "Immunovia Delarsrapport Q2 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a34ac50a6b43e88fafab56acaa607b867", "final_url": "https://attachment.news.eu.nasdaq.com/a34ac50a6b43e88fafab56acaa607b867", "filename": "Immunovia_Delarsrapport_Q2_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q2\\Immunovia_Delarsrapport_Q2_2025.pdf", "content_type": "application/pdf", "size": 2848743, "sha256": "cdfeedad1fe434d611f256fabfc55b97bcec98532c0badfbc45ba8a722de0883", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q2\\Immunovia_Delarsrapport_Q2_2025.pdf", "filename": "Immunovia_Delarsrapport_Q2_2025.pdf", "extension": ".pdf", "size": 2848743, "sha256": "cdfeedad1fe434d611f256fabfc55b97bcec98532c0badfbc45ba8a722de0883", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q2\\extracted\\Immunovia_Delarsrapport_Q2_2025\\Immunovia_Delarsrapport_Q2_2025.txt", "text_chars": 52590, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q2\\extracted\\Immunovia_Delarsrapport_Q2_2025\\Immunovia_Delarsrapport_Q2_2025.extraction.json" } } ], "announcement_id": "1385713", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:11:06Z", "company": "Immunovia AB", "title": "Immunovia publicerar Delårsrapport januari-mars 2025", "category": "Interimsrapport", "date": "2025-05-14", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b41388f6bed50cdb8c4704cb71e9c73c6&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "Immunovia Delarsrapport Q1 2025.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4c207209390b4129817aaef9aed0e724", "final_url": "https://attachment.news.eu.nasdaq.com/a4c207209390b4129817aaef9aed0e724", "filename": "Immunovia_Delarsrapport_Q1_2025.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q1\\Immunovia_Delarsrapport_Q1_2025.pdf", "content_type": "application/pdf", "size": 2373675, "sha256": "0998c3898b3b41de80babf449ac83e5b37f5faa319bc1318556c743722283306", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q1\\Immunovia_Delarsrapport_Q1_2025.pdf", "filename": "Immunovia_Delarsrapport_Q1_2025.pdf", "extension": ".pdf", "size": 2373675, "sha256": "0998c3898b3b41de80babf449ac83e5b37f5faa319bc1318556c743722283306", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q1\\extracted\\Immunovia_Delarsrapport_Q1_2025\\Immunovia_Delarsrapport_Q1_2025.txt", "text_chars": 49052, "metadata": { "page_count": 25, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2025-q1\\extracted\\Immunovia_Delarsrapport_Q1_2025\\Immunovia_Delarsrapport_Q1_2025.extraction.json" } } ], "announcement_id": "1363110", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:11:13Z", "company": "Immunovia AB", "title": "Immunovia publicerar årsredovisningen för 2024", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-04-02", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=bc44d41fa956d8be3c0465865957090ee&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "04010960.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad8f82bcabe6b205567357ba5b348dd01", "final_url": "https://attachment.news.eu.nasdaq.com/ad8f82bcabe6b205567357ba5b348dd01", "filename": "04010960.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-annual\\04010960.pdf", "content_type": "application/pdf", "size": 4387499, "sha256": "a4515cc4b07797264935dbcff2789cfdf6bf2969bf78883aebc2bec5143746bd", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-annual\\04010960.pdf", "filename": "04010960.pdf", "extension": ".pdf", "size": 4387499, "sha256": "a4515cc4b07797264935dbcff2789cfdf6bf2969bf78883aebc2bec5143746bd", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-annual\\extracted\\04010960\\04010960.txt", "text_chars": 171458, "metadata": { "page_count": 73, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-annual\\extracted\\04010960\\04010960.extraction.json" } } ], "announcement_id": "1353043", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:11:21Z", "company": "Immunovia AB", "title": "Immunovia publicerar Bokslutskommuniké 2024", "category": "Bokslutskommuniké", "date": "2025-02-25", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b212d1c22005999027287c160918d11a0&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "Immunovia publicerar Bokslutskommunike 2024_SV.pdf", "url": "https://attachment.news.eu.nasdaq.com/a5d27304d3af3f62d0cbbd3999afa7d08", "final_url": "https://attachment.news.eu.nasdaq.com/a5d27304d3af3f62d0cbbd3999afa7d08", "filename": "Immunovia_publicerar_Bokslutskommunike_2024_SV.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q4\\Immunovia_publicerar_Bokslutskommunike_2024_SV.pdf", "content_type": "application/pdf", "size": 439084, "sha256": "cc850c231250b5ae6d83e0fd21d9e13b92b926755f323e38ac325864d42cd7d0", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q4\\Immunovia_publicerar_Bokslutskommunike_2024_SV.pdf", "filename": "Immunovia_publicerar_Bokslutskommunike_2024_SV.pdf", "extension": ".pdf", "size": 439084, "sha256": "cc850c231250b5ae6d83e0fd21d9e13b92b926755f323e38ac325864d42cd7d0", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q4\\extracted\\Immunovia_publicerar_Bokslutskommunike_2024_S\\Immunovia_publicerar_Bokslutskommunike_2024_SV.txt", "text_chars": 13318, "metadata": { "page_count": 7, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q4\\extracted\\Immunovia_publicerar_Bokslutskommunike_2024_S\\Immunovia_publicerar_Bokslutskommunike_2024_SV.extraction.json" } }, { "label": "02241926.pdf", "url": "https://attachment.news.eu.nasdaq.com/abe1f005fa7d4e8f7d69c5443ceb81adf", "final_url": "https://attachment.news.eu.nasdaq.com/abe1f005fa7d4e8f7d69c5443ceb81adf", "filename": "02241926.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q4\\02241926.pdf", "content_type": "application/pdf", "size": 2250676, "sha256": "05a51c33048ff12a3e5f66bd75db3a908aaa5cb10acc4deee349495cf05e0f99", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q4\\02241926.pdf", "filename": "02241926.pdf", "extension": ".pdf", "size": 2250676, "sha256": "05a51c33048ff12a3e5f66bd75db3a908aaa5cb10acc4deee349495cf05e0f99", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q4\\extracted\\02241926\\02241926.txt", "text_chars": 52992, "metadata": { "page_count": 25, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q4\\extracted\\02241926\\02241926.extraction.json" } } ], "announcement_id": "1345017", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:11:32Z", "company": "Immunovia AB", "title": "Immunovia publicerar Delårsrapport januari-september 2024", "category": "Interimsrapport", "date": "2024-11-27", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b8b53f31aecfb743c65abdf35b7833931&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "11263202.pdf", "url": "https://attachment.news.eu.nasdaq.com/acd18c866d911da5e4edb17009d06304a", "final_url": "https://attachment.news.eu.nasdaq.com/acd18c866d911da5e4edb17009d06304a", "filename": "11263202.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q3\\11263202.pdf", "content_type": "application/pdf", "size": 2204675, "sha256": "3a806c9f778c8ff2f04b94fd3a6cadfaaae0eedeae12f90fae764ae9eacf0266", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q3\\11263202.pdf", "filename": "11263202.pdf", "extension": ".pdf", "size": 2204675, "sha256": "3a806c9f778c8ff2f04b94fd3a6cadfaaae0eedeae12f90fae764ae9eacf0266", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q3\\extracted\\11263202\\11263202.txt", "text_chars": 52618, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q3\\extracted\\11263202\\11263202.extraction.json" } }, { "label": "Immunovia publicerar Delarsrapport januari-september 2024 .pdf", "url": "https://attachment.news.eu.nasdaq.com/a6a7519e5849970ba1a802565497b5860", "final_url": "https://attachment.news.eu.nasdaq.com/a6a7519e5849970ba1a802565497b5860", "filename": "Immunovia_publicerar_Delarsrapport_januari-september_2024_.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q3\\Immunovia_publicerar_Delarsrapport_januari-september_2024_.pdf", "content_type": "application/pdf", "size": 350775, "sha256": "98da8f4fa607a1e123fd7fd0defed94202a46d2a94a9676361227d68b066b9fd", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q3\\Immunovia_publicerar_Delarsrapport_januari-september_2024_.pdf", "filename": "Immunovia_publicerar_Delarsrapport_januari-september_2024_.pdf", "extension": ".pdf", "size": 350775, "sha256": "98da8f4fa607a1e123fd7fd0defed94202a46d2a94a9676361227d68b066b9fd", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q3\\extracted\\Immunovia_publicerar_Delarsrapport_januari-se\\Immunovia_publicerar_Delarsrapport_januari-septemb.txt", "text_chars": 12916, "metadata": { "page_count": 6, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q3\\extracted\\Immunovia_publicerar_Delarsrapport_januari-se\\Immunovia_publicerar_Delarsrapport_januari-septemb.extraction.json" } } ], "announcement_id": "1330074", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:11:41Z", "company": "Immunovia AB", "title": "Immunovia publicerar Delårsrapport januari-juni 2024", "category": "Halvårsrapport", "date": "2024-08-05", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b25c580428d5814df1e00619cdca80c88&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "08041669.pdf", "url": "https://attachment.news.eu.nasdaq.com/af0c0fc60f1be8e297da6c1197aa1fd20", "final_url": "https://attachment.news.eu.nasdaq.com/af0c0fc60f1be8e297da6c1197aa1fd20", "filename": "08041669.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q2\\08041669.pdf", "content_type": "application/pdf", "size": 1839785, "sha256": "df5a5c22c0fd818bab44b1bf857e17f3598c490f53539889486bf2758bb0e91a", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q2\\08041669.pdf", "filename": "08041669.pdf", "extension": ".pdf", "size": 1839785, "sha256": "df5a5c22c0fd818bab44b1bf857e17f3598c490f53539889486bf2758bb0e91a", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q2\\extracted\\08041669\\08041669.txt", "text_chars": 51580, "metadata": { "page_count": 25, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q2\\extracted\\08041669\\08041669.extraction.json" } }, { "label": "Immunovia publicerar Delarsrapport januari-juni 2024_SV.pdf", "url": "https://attachment.news.eu.nasdaq.com/abe151a0eb1db74db737480a09e09976b", "final_url": "https://attachment.news.eu.nasdaq.com/abe151a0eb1db74db737480a09e09976b", "filename": "Immunovia_publicerar_Delarsrapport_januari-juni_2024_SV.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q2\\Immunovia_publicerar_Delarsrapport_januari-juni_2024_SV.pdf", "content_type": "application/pdf", "size": 386454, "sha256": "6e1ceca4e5db35392ccce27d83b331c6154dba9a048d9d8be08865c6c9f4e3cf", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q2\\Immunovia_publicerar_Delarsrapport_januari-juni_2024_SV.pdf", "filename": "Immunovia_publicerar_Delarsrapport_januari-juni_2024_SV.pdf", "extension": ".pdf", "size": 386454, "sha256": "6e1ceca4e5db35392ccce27d83b331c6154dba9a048d9d8be08865c6c9f4e3cf", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q2\\extracted\\Immunovia_publicerar_Delarsrapport_januari-ju\\Immunovia_publicerar_Delarsrapport_januari-juni_20.txt", "text_chars": 12695, "metadata": { "page_count": 6, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q2\\extracted\\Immunovia_publicerar_Delarsrapport_januari-ju\\Immunovia_publicerar_Delarsrapport_januari-juni_20.extraction.json" } } ], "announcement_id": "1309203", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:11:49Z", "company": "Immunovia AB", "title": "Immunovia publicerar årsredovisningen för 2023", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-04-29", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=bbd4042338269ccc77bd024770608b8d7&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "04299763.pdf", "url": "https://attachment.news.eu.nasdaq.com/a70dcaddefd57dbbd8b33a06aa4bc8ce2", "final_url": "https://attachment.news.eu.nasdaq.com/a70dcaddefd57dbbd8b33a06aa4bc8ce2", "filename": "04299763.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-annual\\04299763.pdf", "content_type": "application/pdf", "size": 3473993, "sha256": "d777c5ae5528db58596f43a25d96705db22e4de68e60408f17d23268cefb6319", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-annual\\04299763.pdf", "filename": "04299763.pdf", "extension": ".pdf", "size": 3473993, "sha256": "d777c5ae5528db58596f43a25d96705db22e4de68e60408f17d23268cefb6319", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-annual\\extracted\\04299763\\04299763.txt", "text_chars": 190758, "metadata": { "page_count": 76, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-annual\\extracted\\04299763\\04299763.extraction.json" } } ], "announcement_id": "1291541", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:11:56Z", "company": "Immunovia AB", "title": "Immunovia publicerar Delårsrapport januari-mars 2024", "category": "Interimsrapport", "date": "2024-04-29", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b4d0abd112c5a082193b9e1be811299f4&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "Immunovia publicerar Delarsrapport januari-mars 2024_SV.pdf", "url": "https://attachment.news.eu.nasdaq.com/a883c6ecc9b2a1f8e9e8f51f3d0fa6c00", "final_url": "https://attachment.news.eu.nasdaq.com/a883c6ecc9b2a1f8e9e8f51f3d0fa6c00", "filename": "Immunovia_publicerar_Delarsrapport_januari-mars_2024_SV.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q1\\Immunovia_publicerar_Delarsrapport_januari-mars_2024_SV.pdf", "content_type": "application/pdf", "size": 371208, "sha256": "d535ceb3894fc6436d9b2cd6de2666c66dfdcf51d0e1a3136ab9d8d24012ad94", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q1\\Immunovia_publicerar_Delarsrapport_januari-mars_2024_SV.pdf", "filename": "Immunovia_publicerar_Delarsrapport_januari-mars_2024_SV.pdf", "extension": ".pdf", "size": 371208, "sha256": "d535ceb3894fc6436d9b2cd6de2666c66dfdcf51d0e1a3136ab9d8d24012ad94", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q1\\extracted\\Immunovia_publicerar_Delarsrapport_januari-ma\\Immunovia_publicerar_Delarsrapport_januari-mars_20.txt", "text_chars": 10889, "metadata": { "page_count": 5, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q1\\extracted\\Immunovia_publicerar_Delarsrapport_januari-ma\\Immunovia_publicerar_Delarsrapport_januari-mars_20.extraction.json" } }, { "label": "04289478.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4e47857722f4af0dda08663c0e7fa1a0", "final_url": "https://attachment.news.eu.nasdaq.com/a4e47857722f4af0dda08663c0e7fa1a0", "filename": "04289478.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q1\\04289478.pdf", "content_type": "application/pdf", "size": 1645751, "sha256": "5d01116aeaa35137c5bc6e02fba92f7dc66eaaf2032bf2cd528e3d0173bc83f4", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q1\\04289478.pdf", "filename": "04289478.pdf", "extension": ".pdf", "size": 1645751, "sha256": "5d01116aeaa35137c5bc6e02fba92f7dc66eaaf2032bf2cd528e3d0173bc83f4", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q1\\extracted\\04289478\\04289478.txt", "text_chars": 47070, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2024-q1\\extracted\\04289478\\04289478.extraction.json" } } ], "announcement_id": "1291480", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:12:05Z", "company": "Immunovia AB", "title": "Immunovia publicerar Bokslutskommuniké 2023", "category": "Bokslutskommuniké", "date": "2024-02-21", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b91785184b96209906ea0184ec9195341&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "Immunovia publicerar Bokslutskommunike 2023_SV.pdf", "url": "https://attachment.news.eu.nasdaq.com/a72ff61d7cdc83e2654216be87f7bda23", "final_url": "https://attachment.news.eu.nasdaq.com/a72ff61d7cdc83e2654216be87f7bda23", "filename": "Immunovia_publicerar_Bokslutskommunike_2023_SV.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q4\\Immunovia_publicerar_Bokslutskommunike_2023_SV.pdf", "content_type": "application/pdf", "size": 402001, "sha256": "c151a2008169b6f1de11dc6adb4c812fe6715a8c9a4fdaeb7f74da1fc8bb9787", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q4\\Immunovia_publicerar_Bokslutskommunike_2023_SV.pdf", "filename": "Immunovia_publicerar_Bokslutskommunike_2023_SV.pdf", "extension": ".pdf", "size": 402001, "sha256": "c151a2008169b6f1de11dc6adb4c812fe6715a8c9a4fdaeb7f74da1fc8bb9787", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q4\\extracted\\Immunovia_publicerar_Bokslutskommunike_2023_S\\Immunovia_publicerar_Bokslutskommunike_2023_SV.txt", "text_chars": 15410, "metadata": { "page_count": 6, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q4\\extracted\\Immunovia_publicerar_Bokslutskommunike_2023_S\\Immunovia_publicerar_Bokslutskommunike_2023_SV.extraction.json" } }, { "label": "02202332.pdf", "url": "https://attachment.news.eu.nasdaq.com/a6a47d32a9fd60e7b8bd200d032a951f0", "final_url": "https://attachment.news.eu.nasdaq.com/a6a47d32a9fd60e7b8bd200d032a951f0", "filename": "02202332.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q4\\02202332.pdf", "content_type": "application/pdf", "size": 2369868, "sha256": "20dcbea82e241e3a7bedc430d19d1720115f11eee5508a11099b01cb5c79b86f", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q4\\02202332.pdf", "filename": "02202332.pdf", "extension": ".pdf", "size": 2369868, "sha256": "20dcbea82e241e3a7bedc430d19d1720115f11eee5508a11099b01cb5c79b86f", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q4\\extracted\\02202332\\02202332.txt", "text_chars": 57447, "metadata": { "page_count": 28, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q4\\extracted\\02202332\\02202332.extraction.json" } } ], "announcement_id": "1276274", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:12:15Z", "company": "Immunovia AB", "title": "Immunovia publicerar Delårsrapport januari-september 2023", "category": "Interimsrapport", "date": "2023-11-09", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=bdaf84d6ee2ea08b443bd4c0baa498b72&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "Immunovia publicerar Delarsrapport januari-september 2023_SE.pdf", "url": "https://attachment.news.eu.nasdaq.com/a8bb020a6131afd6dca358a42293a841c", "final_url": "https://attachment.news.eu.nasdaq.com/a8bb020a6131afd6dca358a42293a841c", "filename": "Immunovia_publicerar_Delarsrapport_januari-september_2023_SE.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q3\\Immunovia_publicerar_Delarsrapport_januari-september_2023_SE.pdf", "content_type": "application/pdf", "size": 369287, "sha256": "cb1667a58784803854d8ea0cd81d34de3f6ee9405d6eaadc9c103c22b203d193", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q3\\Immunovia_publicerar_Delarsrapport_januari-september_2023_SE.pdf", "filename": "Immunovia_publicerar_Delarsrapport_januari-september_2023_SE.pdf", "extension": ".pdf", "size": 369287, "sha256": "cb1667a58784803854d8ea0cd81d34de3f6ee9405d6eaadc9c103c22b203d193", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q3\\extracted\\Immunovia_publicerar_Delarsrapport_januari-se\\Immunovia_publicerar_Delarsrapport_januari-septemb.txt", "text_chars": 11996, "metadata": { "page_count": 5, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q3\\extracted\\Immunovia_publicerar_Delarsrapport_januari-se\\Immunovia_publicerar_Delarsrapport_januari-septemb.extraction.json" } }, { "label": "11081246.pdf", "url": "https://attachment.news.eu.nasdaq.com/aec57324595315300aeeaee2a72ce03c8", "final_url": "https://attachment.news.eu.nasdaq.com/aec57324595315300aeeaee2a72ce03c8", "filename": "11081246.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q3\\11081246.pdf", "content_type": "application/pdf", "size": 2558798, "sha256": "5081fce965b0350cac4df4eaad2f897e4684914745bee61c519ec6e2a962c46d", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q3\\11081246.pdf", "filename": "11081246.pdf", "extension": ".pdf", "size": 2558798, "sha256": "5081fce965b0350cac4df4eaad2f897e4684914745bee61c519ec6e2a962c46d", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q3\\extracted\\11081246\\11081246.txt", "text_chars": 56339, "metadata": { "page_count": 28, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q3\\extracted\\11081246\\11081246.extraction.json" } } ], "announcement_id": "1258202", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:12:23Z", "company": "Immunovia AB", "title": "Immunovia publicerar Delårsrapport januari-juni 2023", "category": "Halvårsrapport", "date": "2023-08-30", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b371e6323aef2194d84e4c7ecc2d89e30&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "08294671.pdf", "url": "https://attachment.news.eu.nasdaq.com/aef1296542205e39180d2c63a5aa2de4b", "final_url": "https://attachment.news.eu.nasdaq.com/aef1296542205e39180d2c63a5aa2de4b", "filename": "08294671.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q2\\08294671.pdf", "content_type": "application/pdf", "size": 2101728, "sha256": "d3df7868ec951e4987f7a56ad78374700ecc020c9947dc06d022301d0b5ac249", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q2\\08294671.pdf", "filename": "08294671.pdf", "extension": ".pdf", "size": 2101728, "sha256": "d3df7868ec951e4987f7a56ad78374700ecc020c9947dc06d022301d0b5ac249", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q2\\extracted\\08294671\\08294671.txt", "text_chars": 55030, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q2\\extracted\\08294671\\08294671.extraction.json" } }, { "label": "Immunovia publicerar Delarsrapport januari-juni 2023_SV1.pdf", "url": "https://attachment.news.eu.nasdaq.com/a2813db53c1375cba231b5f06f6b6d7ff", "final_url": "https://attachment.news.eu.nasdaq.com/a2813db53c1375cba231b5f06f6b6d7ff", "filename": "Immunovia_publicerar_Delarsrapport_januari-juni_2023_SV1.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q2\\Immunovia_publicerar_Delarsrapport_januari-juni_2023_SV1.pdf", "content_type": "application/pdf", "size": 396288, "sha256": "9bdc535172caa3bb43a35d8fff548cdde7cdf9e048018046901f57b20cf04d41", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q2\\Immunovia_publicerar_Delarsrapport_januari-juni_2023_SV1.pdf", "filename": "Immunovia_publicerar_Delarsrapport_januari-juni_2023_SV1.pdf", "extension": ".pdf", "size": 396288, "sha256": "9bdc535172caa3bb43a35d8fff548cdde7cdf9e048018046901f57b20cf04d41", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q2\\extracted\\Immunovia_publicerar_Delarsrapport_januari-ju\\Immunovia_publicerar_Delarsrapport_januari-juni_20.txt", "text_chars": 12567, "metadata": { "page_count": 6, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q2\\extracted\\Immunovia_publicerar_Delarsrapport_januari-ju\\Immunovia_publicerar_Delarsrapport_januari-juni_20.extraction.json" } } ], "announcement_id": "1245239", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-04-fresh-local-files-v5.0.2", "retrieved_at": "2026-08-07T04:12:35Z", "company": "Immunovia AB", "title": "Immunovia publicerar Delårsrapport januari-mars 2023", "category": "Interimsrapport", "date": "2023-05-23", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b81a20371a4ce5834b89f9ae6b27303b4&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "Immunovia publicerar Delarsrapport januari-mars 2023_SV.pdf", "url": "https://attachment.news.eu.nasdaq.com/a51558d2cf699ab8593d818a7cdbd8ca8", "final_url": "https://attachment.news.eu.nasdaq.com/a51558d2cf699ab8593d818a7cdbd8ca8", "filename": "Immunovia_publicerar_Delarsrapport_januari-mars_2023_SV.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q1\\Immunovia_publicerar_Delarsrapport_januari-mars_2023_SV.pdf", "content_type": "application/pdf", "size": 366267, "sha256": "55e49b7bd955cb5f7ce85a074909d94f729f43da73899371a063f510c990dacd", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q1\\Immunovia_publicerar_Delarsrapport_januari-mars_2023_SV.pdf", "filename": "Immunovia_publicerar_Delarsrapport_januari-mars_2023_SV.pdf", "extension": ".pdf", "size": 366267, "sha256": "55e49b7bd955cb5f7ce85a074909d94f729f43da73899371a063f510c990dacd", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q1\\extracted\\Immunovia_publicerar_Delarsrapport_januari-ma\\Immunovia_publicerar_Delarsrapport_januari-mars_20.txt", "text_chars": 14657, "metadata": { "page_count": 6, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q1\\extracted\\Immunovia_publicerar_Delarsrapport_januari-ma\\Immunovia_publicerar_Delarsrapport_januari-mars_20.extraction.json" } }, { "label": "05220986.pdf", "url": "https://attachment.news.eu.nasdaq.com/a624425c262bab7d0258e72e8ab48e1f2", "final_url": "https://attachment.news.eu.nasdaq.com/a624425c262bab7d0258e72e8ab48e1f2", "filename": "05220986.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q1\\05220986.pdf", "content_type": "application/pdf", "size": 2196579, "sha256": "dcf8f047fbd1ff2984ea9e64777cc635cc14a2016082b71926900a213fd51942", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q1\\05220986.pdf", "filename": "05220986.pdf", "extension": ".pdf", "size": 2196579, "sha256": "dcf8f047fbd1ff2984ea9e64777cc635cc14a2016082b71926900a213fd51942", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q1\\extracted\\05220986\\05220986.txt", "text_chars": 50387, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\immunovia\\nasdaq-reports\\reports\\2023-q1\\extracted\\05220986\\05220986.extraction.json" } } ], "announcement_id": "1229444", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "8778531f2e3195bc77024c6927d7404bf25577640bc20f631e18e897a1ecbc65" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "7767188143c681bb0beab4484b113d2306d60b21c55b8482a1fd9d5173254d06" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "06fb9846435f8ae1683ec04e11f8462f15e44ae39e82c1b144303ca1ecdb436e" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 54, "new_rows": 54, "total_count": null, "from_cache": false, "body_sha256": "9bbc52e70f7017b7fbe09bbc7282d832300e4acc0a73f7b45e8cc61f0d82a2ca" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=354&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 354, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "004c65f6984586b4ba54cd25478ff0d35a3782adee17c837134c5a6b94206322" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 5, "new_rows": 5, "total_count": null, "from_cache": false, "body_sha256": "625d9f2eeded6fa9aeb4b6d62d7c353880d446b1e78cd4be472b3857e501dea6" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=5&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 5, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "d97ee824ab5793095b25a383238d191f6e98476d65197a4c886f360e00a0680f" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "02d765e9b2169b8f19ed6a07152eaca8bdbed57889425282a449a86e4d151eea" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "3df62a766167e8eef97e1c51b74a47010257327c4505b81c3cf050345d16f371" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "6fdfefe71961f8c4759fa34cab7d0a9211e30f1234f8f5a759b77c1608e6252d" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 300, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 48, "new_rows": 48, "total_count": null, "from_cache": false, "body_sha256": "10a456a087abb57ccc5fc61abfae7a654efffdcb142ea8b736c8242df827fc17" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=348&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 348, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "d1a6c0de5ff3ca78e97c2a9ab7cee8e6d2bf8ebb3934111845546402a33bcf37" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 3, "new_rows": 3, "total_count": null, "from_cache": false, "body_sha256": "52041c57c1bd79d7224c218ab910ba4d99f77c468795d3bc0c7fe5635d432368" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=Immunovia&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=3&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 3, "pagination": "row-offset", "query_text": "Immunovia", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "449de37c3458e07fa7a04e480e0ef1298d825283b8c7f36964108a8672015b9a" } ], "identity": { "slug": "", "instrument_id": "TX1932150", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/immnov?id=TX1932150" }, "transport": "ordinary-http", "browser_used": false, "query_text": "Immunovia", "retrieved_at": "2026-08-07T04:12:35Z" }